Vivo Capital, LLC Q4 2025 Filing
Filed February 13, 2026
Portfolio Value
$1.5B
Holdings
47
Report Date
Q4 2025
Filing Type
13F-HR
All Holdings (47 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | TERNTerns Pharmaceuticals Inc | 5,346,928 | $216.0M | 13.96% | |
| 2 | CDTXCidara Therapeutics, Inc. | 956,670 | $211.3M | 13.66% | |
| 3 | PRAXPraxis Precision Medicines | 328,895 | $96.9M | 6.27% | |
| 4 | COGTCogent Biosciences Inc | 2,398,993 | $85.2M | 5.51% | |
| 5 | TRVITrevi Therapeutics Inc | 5,094,668 | $63.8M | 4.12% | |
| 6 | AVDLAvadel Pharmaceuticals PLC | 2,684,109 | $57.8M | 3.74% | |
| 7 | CMPXCompass Therapeutics Inc | 9,545,466 | $51.3M | 3.31% | |
| 8 | DYNDyne Therapeutics Inc | 2,614,960 | $51.1M | 3.31% | |
| 9 | ABVXAbivax SA - ADR | 359,305 | $48.5M | 3.13% | |
| 10 | DBVTDBV Technologies SA | 2,461,626 | $47.2M | 3.05% | |
| 11 | SABSSAB Biotherapeutics Inc | 11,420,000 | $42.7M | 2.76% | |
| 12 | SLNOSoleno Therapeutics Inc | 894,909 | $41.4M | 2.68% | |
| 13 | DRUGBright Minds Biosciences Inc | 501,617 | $39.1M | 2.53% | |
| 14 | SVASinovac Biotech Ltd. | 5,903,000 | $38.2M | 2.47% | |
| 15 | GONGeron Corp | 27,225,292 | $35.9M | 2.32% | |
| 16 | ERASErasca Inc | 9,273,428 | $34.5M | 2.23% | |
| 17 | ZBIOZenas Biopharma Inc | 853,495 | $31.0M | 2.00% | |
| 18 | VRDNViridian Therapeutics Inc | 982,576 | $30.6M | 1.98% | |
| 19 | ACRSAclaris Therapeutics, Inc. | 8,888,888 | $26.8M | 1.73% | |
| 20 | CAMPCAMP4 Therapeutics Inc | 4,246,568 | $26.0M | 1.68% | |
| 21 | TNGXTango Therapeutics Inc | 2,154,780 | $19.1M | 1.23% | |
| 22 | ANROAlto Neuroscience Inc | 1,035,551 | $18.4M | 1.19% | |
| 23 | LBRXLB Pharmaceuticals Inc | 800,000 | $17.8M | 1.15% | |
| 24 | NERVMinerva Neurosciences Inc | 4,322,747 | $17.4M | 1.12% | |
| 25 | ORICOric Pharmaceuticals Inc | 2,118,384 | $17.3M | 1.12% | |
| 26 | CRVSCorvus Pharmaceuticals Holdings | 2,234,566 | $17.2M | 1.11% | |
| 27 | OLMAOlema Pharmaceuticals Inc | 671,843 | $16.8M | 1.09% | |
| 28 | PEPGPepgen Inc | 2,325,000 | $15.1M | 0.98% | |
| 29 | DSGNDesign Therapeutics Inc | 1,612,903 | $15.1M | 0.98% | |
| 30 | DNTHDianthus Therapeutics Inc | 353,998 | $14.6M | 0.94% | |
| 31 | MLTXMoonlake Immunotherapeutics | 1,000,000 | $13.2M | 0.85% | |
| 32 | CTMXCytomx Therapeutics Inc | 2,884,615 | $12.3M | 0.79% | |
| 33 | UNCYUnicycive Therapeutics | 1,789,916 | $10.3M | 0.67% | |
| 34 | EPRXEupraxia Pharmaceuticals Inc | 1,350,000 | $10.2M | 0.66% | |
| 35 | ABEOAbeona Therapeutics, Inc. | 1,842,751 | $9.7M | 0.63% | |
| 36 | VSTMVerastem Inc | 1,106,524 | $8.5M | 0.55% | |
| 37 | SLNSilence Therapeutics PLC | 1,105,454 | $6.7M | 0.43% | |
| 38 | MNPRMonopar Therapeutics Inc | 90,500 | $5.9M | 0.38% | |
| 39 | SRZNSurrozen Inc | 260,000 | $5.9M | 0.38% | |
| 40 | PALIPalisade Bio Inc | 2,293,578 | $5.4M | 0.35% | |
| 41 | SERASera Prognostics Inc | 1,650,440 | $4.9M | 0.31% | |
| 42 | TILInstil Bio Inc | 292,743 | $3.2M | 0.21% | |
| 43 | KTTAPasithea Therapeutics Corp | 2,100,000 | $2.7M | 0.18% | |
| 44 | TENXTenax Therapeutics Inc | 208,333 | $2.5M | 0.16% | |
| 45 | ENGNWEnGene Holdings Inc | 285,046 | $843K | 0.05% | |
| 46 | BOLTBolt Therapeutics Inc | 72,414 | $395K | 0.03% | |
| 47 | DTILPrecision Biosciences Inc | 4,675 | $19K | 0.00% |